Leopoldo Fernández-Domper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leopoldo Fernández-Domper has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Esmeralda Silva Díaz
Servicio de Dermatología, Hospital Clínico Universitario de Valencia, Valencia, España
2 shared publications J.A. Páramo
Laboratorio de Aterotrombosis, Programa de Enfermedades Cardiovasculares, Cima Universidad de Navarra. IdiSNA, Instituto de Investigación Sanitaria de Navarra.Laboratorio de Insuficiencia Cardiaca, Programa de Enfermedades Cardiovasculares, Cima Universidad de Navarra. Servicio de Hematología, Clínica Universidad de Navarra, Spain
2 shared publicationsJ.M. Martin Hernández
Departamento de Dermatología, Hospital Clínico Universitario, Universidad de Valencia, Spain
2 shared publicationsJose A. Páramo
Laboratory of Atherothrombotic, Program of Cardiovascular Diseases, CIMA Universidad de Navarra, Pamplona, Spain
2 shared publicationsL. Fernández Alonso
Departamento de Angiología y Cirugía Vascular, Complejo Hospitalario de Navarra.IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain
2 shared publicationsLeopoldo Fernández Alonso
Navarra University Hospital
2 shared publications
Latest Publications
- Open Access
- 11 March 2025
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 116 (5) , T521-T526
[Translated article] Triglyceride-glucose Index as a Predictor of Cardiovascular Events in Psoriatic Patients on Systemic Therapy: A 150-patient Observational Study
- 11 March 2025
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 116 (5) , T521-T526
Open Access[Translated article] Triglyceride-glucose Index as a Predictor of Cardiovascular Events in Psoriatic Patients on Systemic Therapy: A 150-patient Observational Study
- Open Access
- 2 January 2025
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 116 (5) , 521-526
El índice triglicéridos-glucosa como predictor de eventos cardiovasculares en pacientes con psoriasis y tratamiento sistémico: un estudio observacional de 150 pacientes
- 2 January 2025
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 116 (5) , 521-526
Open AccessEl índice triglicéridos-glucosa como predictor de eventos cardiovasculares en pacientes con psoriasis y tratamiento sistémico: un estudio observacional de 150 pacientes
- 2 May 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (5) , 1-4
Novel biomarkers and psoriasis associated cardiovascular risk
- 2 May 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (5) , 1-4
Novel biomarkers and psoriasis associated cardiovascular risk
- Open Access
- 2 January 2024
- Published by Springer Nature in Research Square
Novel biomarkers and psoriasis associated cardiovascular risk: a population-based study
Background Despite the established link between psoriasis and cardiovascular risk (CVR), there remains a crucial need for improved risk stratification in this patient population.Material and Methods A descriptive cross-sectional non-controlled study was carried out on patients evaluated in the Dermatology Department of the Valencia University Clinical Hospital between 2017 and 2022. The primary endpoint of our study was to characterize patients diagnosed with moderate to severe psoriasis, focusing on their major adverse cardiovascular events (MACE) as well as new metabolic and hematological parameters, such as triglycerides to glucose (TyG) index, neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR).Results A total of 150 patients with moderate to severe psoriasis, defined by a psoriasis area severity index (PASI) > 10 during their evolution, were collected. The mean age was 50.76 years and the mean body mass index (BMI) was 28.62, defining the overweight population. Psoriatic arthritis was present in 14.7%. As CVR factors, 40.7% were smokers, 17.3% had diabetes mellitus, 24% hypertension and 30.7% dyslipidemia. As MACE, 11 acute myocardial infarction (AMI) and 1 stroke were recorded.Conclusion Novel biomarkers such has TGI, NLR or PLR hold great potential in optimizing the management and prevention of cardiovascular diseases in this vulnerable population. Our psoriasis population is similar in clinical and demographic terms, as well as in incidence of metabolic comorbidities and cardiovascular events to other series published to date.
- 2 January 2024
- Published by Springer Nature in Research Square
Open AccessNovel biomarkers and psoriasis associated cardiovascular risk: a population-based study
Background Despite the established link between psoriasis and cardiovascular risk (CVR), there remains a crucial need for improved risk stratification in this patient population.Material and Methods A descriptive cross-sectional non-controlled study was carried out on patients evaluated in the Dermatology Department of the Valencia University Clinical Hospital between 2017 and 2022. The primary endpoint of our study was to characterize patients diagnosed with moderate to severe psoriasis, focusing on their major adverse cardiovascular events (MACE) as well as new metabolic and hematological parameters, such as triglycerides to glucose (TyG) index, neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR).Results A total of 150 patients with moderate to severe psoriasis, defined by a psoriasis area severity index (PASI) > 10 during their evolution, were collected. The mean age was 50.76 years and the mean body mass index (BMI) was 28.62, defining the overweight population. Psoriatic arthritis was present in 14.7%. As CVR factors, 40.7% were smokers, 17.3% had diabetes mellitus, 24% hypertension and 30.7% dyslipidemia. As MACE, 11 acute myocardial infarction (AMI) and 1 stroke were recorded.Conclusion Novel biomarkers such has TGI, NLR or PLR hold great potential in optimizing the management and prevention of cardiovascular diseases in this vulnerable population. Our psoriasis population is similar in clinical and demographic terms, as well as in incidence of metabolic comorbidities and cardiovascular events to other series published to date.
- Open Access
- 29 April 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (2) , e2023098
Dermoscopy of Abortive Hemangioma: Morphological Study of 11 Cases
Citation: Fernández Domper L, Silva Diaz E, Ballesteros Redondo M, Martín Hernández JM, Revert Fernandez A. Dermoscopy of Abortive Hemangioma: Morphological Study of 11 Cases. Dermatol Pract Concept. 2023;13(2):e2023098. DOI: https://doi.org/10.5826/dpc.1302a98 Accepted: August 31, 2023; Published: April 2023 Copyright: ©2023 Fernández Domper et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: This research was supported by the Dermatology Department of the Clinical Universitary Hospital of Valencia. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Leopoldo Fernández Domper, MD, Department of Dermatology Hospital Clínico Universitario de Valencia, Blasco Ibañez Avenue, 17, Valencia, Comunidad Valenciana, 46010, Spain Tel: +34636683965 E-mail: lfernandezdomper@gmail.com Keywords : Dermoscopy, Infantile hemangioma, Vascular Anomalies, abortive hemangioma This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- 29 April 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (2) , e2023098
Open AccessDermoscopy of Abortive Hemangioma: Morphological Study of 11 Cases
Citation: Fernández Domper L, Silva Diaz E, Ballesteros Redondo M, Martín Hernández JM, Revert Fernandez A. Dermoscopy of Abortive Hemangioma: Morphological Study of 11 Cases. Dermatol Pract Concept. 2023;13(2):e2023098. DOI: https://doi.org/10.5826/dpc.1302a98 Accepted: August 31, 2023; Published: April 2023 Copyright: ©2023 Fernández Domper et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: This research was supported by the Dermatology Department of the Clinical Universitary Hospital of Valencia. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Leopoldo Fernández Domper, MD, Department of Dermatology Hospital Clínico Universitario de Valencia, Blasco Ibañez Avenue, 17, Valencia, Comunidad Valenciana, 46010, Spain Tel: +34636683965 E-mail: lfernandezdomper@gmail.com Keywords : Dermoscopy, Infantile hemangioma, Vascular Anomalies, abortive hemangioma This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- Open Access
- 25 February 2023
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 114 (4) , T327-T333
[Translated article] Trichoscopy: An Update
- 25 February 2023
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 114 (4) , T327-T333
Open Access[Translated article] Trichoscopy: An Update
- Open Access
- 24 December 2022
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 114 (4) , 327-333
Actualización en tricoscopia
- 24 December 2022
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 114 (4) , 327-333
Open AccessActualización en tricoscopia
- Open Access
- 21 October 2022
- Published by Wiley in JEADV Clinical Practice
- Vol. 1 (4) , 397-406
Neutrophil‐to‐lymphocyte ratio as a cardiovascular risk biomarker in psoriasis: A comprehensive review
Background: Psoriasis is a chronic and inflammatory cutaneous disease and it is associated with high cardiovascular risk (CVR). Studies have demonstrated that neutrophils may play a role in CVR in psoriasis. Neutrophil‐to‐lymphocyte ratio (NLR) is a readily available inflammatory biomarker that predicts the development of psoriasis and psoriatic arthritis and is associated with atherosclerosis and cardiovascular (CV) events.Objectives: The aim of this review is to analyze the association between NLR and the presence or risk to develop cardiovascular disease (CVD) in psoriasis patients.Methods: A comprehensive literature research was carried out through Pubmed, Embase and Web of Science to identify all the evidence related to NLR and CVD in psoriasis population. We enrolled all cohort, case‐control and cross‐sectional studies. Duplicated articles and papers without sufficient data were excluded after a full‐text review. Only articles published in English were enrolled in this study.Results: primary searches identified 9 relevant articles. We included 1 observational, 5 case‐control and 3 cross‐sectional studies. NLR was assessed in all studies. As a whole, even though there is a paucity of published evidence, NLR was associated with an increased risk of subclinical atherosclerosis and CVD in all the articles included in this review. The main differences among studies were the sample size and the article design.Conclusion: this review found that NLR is a simple, universally available and routine low‐cost biomarker able to predict CV events in patients with psoriasis. This test will help dermatologists to early detect those patients with psoriasis in whom there is a higher risk of CVD, who can benefit from preventive strategies and treatment settings.
- 21 October 2022
- Published by Wiley in JEADV Clinical Practice
- Vol. 1 (4) , 397-406
Open AccessNeutrophil‐to‐lymphocyte ratio as a cardiovascular risk biomarker in psoriasis: A comprehensive review
Background: Psoriasis is a chronic and inflammatory cutaneous disease and it is associated with high cardiovascular risk (CVR). Studies have demonstrated that neutrophils may play a role in CVR in psoriasis. Neutrophil‐to‐lymphocyte ratio (NLR) is a readily available inflammatory biomarker that predicts the development of psoriasis and psoriatic arthritis and is associated with atherosclerosis and cardiovascular (CV) events.Objectives: The aim of this review is to analyze the association between NLR and the presence or risk to develop cardiovascular disease (CVD) in psoriasis patients.Methods: A comprehensive literature research was carried out through Pubmed, Embase and Web of Science to identify all the evidence related to NLR and CVD in psoriasis population. We enrolled all cohort, case‐control and cross‐sectional studies. Duplicated articles and papers without sufficient data were excluded after a full‐text review. Only articles published in English were enrolled in this study.Results: primary searches identified 9 relevant articles. We included 1 observational, 5 case‐control and 3 cross‐sectional studies. NLR was assessed in all studies. As a whole, even though there is a paucity of published evidence, NLR was associated with an increased risk of subclinical atherosclerosis and CVD in all the articles included in this review. The main differences among studies were the sample size and the article design.Conclusion: this review found that NLR is a simple, universally available and routine low‐cost biomarker able to predict CV events in patients with psoriasis. This test will help dermatologists to early detect those patients with psoriasis in whom there is a higher risk of CVD, who can benefit from preventive strategies and treatment settings.
- Open Access
- 2 May 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (2) , e2022047
Thoracic "Frog Roe" With Zosteriform Distribution
Citation: Fernández Domper L, Ballesteros Redondo M, Hernández JMM, Silva Diaz E. Thoracic frog roes with zosteriform distribution. Dermatol Pract Concept. 2022;12(2):e2022047. DOI: https://doi.org/10.5826/dpc.1202a47 Accepted: July 23, 2021; Published: April 2022 Copyright: ©2022 Fernández Domper et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication Corresponding author: Leopoldo Fernández Domper, Dermatology Department, Hospital Clínico Universitario, Valencia, Spain. Avenida Blasco Ibañez 17, 46010, Valencia, Spain. Email: lfernandezdomper@gmail.com This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- 2 May 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (2) , e2022047
Open AccessThoracic "Frog Roe" With Zosteriform Distribution
Citation: Fernández Domper L, Ballesteros Redondo M, Hernández JMM, Silva Diaz E. Thoracic frog roes with zosteriform distribution. Dermatol Pract Concept. 2022;12(2):e2022047. DOI: https://doi.org/10.5826/dpc.1202a47 Accepted: July 23, 2021; Published: April 2022 Copyright: ©2022 Fernández Domper et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication Corresponding author: Leopoldo Fernández Domper, Dermatology Department, Hospital Clínico Universitario, Valencia, Spain. Avenida Blasco Ibañez 17, 46010, Valencia, Spain. Email: lfernandezdomper@gmail.com This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.